MAM
PASG icon

Marquette Asset Management’s Passage Bio PASG Stock Holding History

Marquette Asset Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,275
Closed -$67.9K – 252
2024
Q2 		$67.9K Hold
4,275
– – 0.01% 134
2024
Q1 		$115K Hold
4,275
– – 0.02% 108
2023
Q4 		$86.4K Sell
4,275
-28
-0.7% -$386 0.02% 118
2023
Q3 		$56.6K Hold
4,303
– – 0.01% 136
2023
Q2 		$81K Hold
4,303
– – 0.02% 132
2023
Q1 		$82.4K Buy
4,303
+948
+28% +$25.7K 0.02% 125
2022
Q4 		$92.6K Buy
+3,355
New +$84.7K 0.03% 113

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marquette Asset Management's PASG Position: Q3 2024 in Review

Marquette Asset Management sold out of Passage Bio (PASG) in Q3 2024, closing a stake of 4,275 shares — an estimated $67.9K sold.

Marquette Asset Management first reported a position in PASG in Q4 2022 and held it in 7 quarters. The position peaked at $115K in Q1 2024. 44 funds tracked by Wall St. Rank hold PASG as of Q3 2024.

  • Marquette Asset Management reported no remaining Passage Bio position as of Q3 2024 after selling out during the quarter.
  • Marquette Asset Management sold 4,275 Passage Bio shares in Q3 2024, an estimated $67.9K.
  • Marquette Asset Management first reported a position in Passage Bio in Q4 2022 and held it in 7 quarters.
  • Marquette Asset Management's Passage Bio position peaked at $115K in Q1 2024.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q3 2024.

Based on Marquette Asset Management's 13F filing for Q3 2024, filed 8 Oct 2024.